Detalhe da pesquisa
1.
Prevalence of Parvovirus B19 Viremia Among German Blood Donations and the Relationship to ABO and Rhesus Blood Group Antigens.
J Infect Dis
; 227(10): 1214-1218, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36408632
2.
Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trialsâ©.
Int J Clin Pharmacol Ther
; 54(11): 847-855, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27719744
3.
Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment.
Transfus Apher Sci
; 39(1): 59-67, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18619902
4.
Tolerability and safety of the intravenous immunoglobulin octagam® 10% in patients with immune thrombocytopenia: a post-authorisation safety analysis of two non-interventional phase IV trials.
Hematology
; 23(4): 242-247, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29020871
5.
Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas) and a development product (Uniplas).
Transfus Apher Sci
; 37(3): 223-31, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18006380
6.
A biochemical comparison of a pharmaceutically licensed coagulation active plasma (Octaplas) with a universally applicable development product (Uniplas) and single-donor FFPs subjected to methylene-blue dye and white-light treatment.
Transfus Apher Sci
; 35(3): 223-33, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17118709
7.
Stability of solvent/detergent-treated plasma and single-donor fresh-frozen plasma during 48 h after thawing.
Transfus Apher Sci
; 33(3): 257-67, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16203177
8.
Dosing of solvent/detergent plasma versus single-donor fresh-frozen plasma.
J Trauma
; 62(4): 1068-9, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17426583
9.
On "Composition, Quality Control, and Labeling of Plasma-Derived Products for the Treatment of von Willebrand disease" (Semin Thromb Hemost 2006;32: 529-536).
Semin Thromb Hemost
; 33(2): 215-6, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17340472